This meeting took place in 2019



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Innate and Non-Classical Immune Cells in Cancer Immunotherapy (C5)


Organizer(s) Nicholas D. Huntington, Eric Vivier, Caroline Robert and Lewis L. Lanier
March 24—28, 2019
Keystone Resort • Keystone, Colorado USA
Discounted Abstract Deadline: Dec 4, 2018
Abstract Deadline: Dec 13, 2018
Scholarship Deadline: Dec 4, 2018
Discounted Registration Deadline: Jan 23, 2019

Sponsored by BioLegend, Inc.

Summary of Meeting:
Immunotherapy has revolutionized the treatment of many cancer types over the past five years. T cell checkpoint inhibitors have led the way and are the focus of most immunotherapy trials. However innate and non-classical T cells contribute extensively to the tumor infiltrate and significantly impact on the tumor immune response in both the tumor microenvironment and in circulation. This symposium aims to bring together academic and industry opinion leaders in the fields of innate immune cells, natural killer cells, tumor microenvironment, tumor immune suppression, novel immunotherapeutic strategies and clinical cancer immunotherapy to define the next wave of immunotherapy breakthroughs that reach beyond the current T cell checkpoints. The conference offers a unique opportunity for an audience of diverse immunology and cancer research backgrounds to come together and share cutting edge insights into cancer immunology and rational approaches for therapeutic intervention that could be used as be standalone therapy or in combination with T cell checkpoint therapies. A key aim is to bring together experts with complementary interest in cancer immunotherapy that would not normally be drawn to common symposia and foster new dynamic collaborations to advance our understanding of tumor immunity.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Viralkumar R. Davra
Rutgers University, USA

National Cancer Institute (NCI) Scholarship Recipients

Davide Bernareggi
University of California, San Diego, USA

Eduardo Bonavita
Cancer Research UK Manchester Institute, University of Manchester, UK

Alvaro Haroun-Izquierdo
Karolinska Institutet, Sweden

Angela L. Tata
Brown University, USA